NEFL and poikiloderma with neutropenia: The study evaluated the reliability and prevalence of several putative neurodegenerative biomarkers, such as neurofilament light chain (NfL), S100B, brain‐derived neurotrophic factor, and neuron‐specific enolase, highlighting the potential of blood‐based biomarkers in assessing nerve involvement in PN patients.